Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Nexstim

10.22 EUR-2.11 %8/9 17:29
5,687 following

NXTMH

First North Finland

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Dividend
Investor views
Compare
-2.11 %
+6.57 %
+13.56 %
+15.61 %
-28.03 %
-21.38 %
+236.18 %
+104.40 %
-98.31 %

Nexstim operates in medical technology. The company has developed a non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with 3D navigation providing targeting of the TMS to the specific area of the brain. The technology is aimed for the treatment of major depression and chronic neuropathic pain. The company was founded in 2000 and has its headquarters in Helsinki.

Read more
Market cap
82.53M EUR
Turnover
52.94K EUR
P/E (adj.) (26e)
124.88
EV/EBIT (adj.) (26e)
62.1
P/B (26e)
8.36
EV/S (26e)
5.82
Dividend yield-% (26e)
-
Coverage
Recommendation
Accumulate
Target price
11.00 EUR
Updated
2026-08-16
Disclaimer
Antti Siltanen
Antti Siltanen

Analyst

Latest research

Latest analysis report

Released: 2026-08-17

Latest extensive report

Released: 2025-06-26

Revenue and EBIT-%
EPS and dividend
Risk
Business risk
Valuation risk
Low
High
All
Research
Press releases
3rd party
ShowingAll content types

Forum discussions
Inderes predicted 52 systems for the whole year. Now we are 12 systems away from that, and the last quarter hasn’t even started yet. And now we are facing the first Q4 where the Brainlab partnership has been active throughout the entire sales pipeline. The rolling 12-month delivery...
9/4/2026, 7:54 AM
by Matti Kukkaro
29
Through Brainlab, sales are certainly weighted toward the end of the year, as the seasonal fluctuation is driven precisely by customers and their decision-making rather than sales resources. In addition to Brainlab, therapy and research equipment are also being sold. In the final...
9/4/2026, 9:37 AM
by Kyhnykeisari
26
I have had a gut feeling for years that Nexstim’s equipment sales news often comes in clusters. I asked GPT to do a deep dive to check this phenomenon across roughly 4.5 years of press release history, from January 24, 2022, to September 4, 2026. When Nexstim has released one piece...
9/6/2026, 1:41 PM
by ekoira
23
Of course, if those (and when) 2x10 have gone to Brainlab, there is already quite a bit to sell for H2. This might change Nexstim’s November-December sales peak. Naturally, they order these in advance. Hopefully, at least one more order of ten would still come in, so we could get...
9/5/2026, 5:55 PM
by Jatast
13
An interesting interview with Giacomo Koch:\n\nHome - INNLIFES few takeaways for those in a hurry…\n\n## Could an approach like this, based on the specific physiology of different neural circuits, pave the way for increasingly personalized neurostimulation protocols?\n\nWe are already...
10 hours ago
by AccionHombre
11
For the past year or two, it has been said that Brainlab’s impact on sales will become prominent for the first time in late 2026… properly. Therefore, given that there has been a considerable number of commenters/experts, I find it hard to believe the scenario you mentioned. Rather...
9/4/2026, 9:18 AM
by Taitoo
10
Aren’t we already in the neighborhood of Inderes’ estimates, or at least not behind by many machines. It’s hard to imagine that a sharp drop from this stock price would be coming if the rest of the year isn’t a “fireworks show” (“tykitystä”) but continues with the same pattern as...
9/4/2026, 7:36 AM
by QRB Strong buy
7
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release2026-09-04 08:00

European University Hospital Orders Nexstim NBS 6 System

Nexstim
Press release2026-09-03 08:00

Nordic Private Clinic Expands Use with Additional NBS 6 System

Nexstim
Third party research2026-09-02 08:11

Nexstim: Stimulating growth with surgical accuracy; INITIATE with BUY - NuWays AG Research

Nexstim is a Finnish MedTech company and a global leader in navigated transcranial magneticstimulation (nTMS) technology. With nTMS, Nexstim helps (i) surgeons preserve patients' motor and speech cortices and (ii) clinicians treat neurological and psychiatric...

Nexstim

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-09-02 08:00

US University Customer Purchases Nexstim NBS 6 for Research Purposes

Nexstim
Press release2026-09-01 08:00

European Hospital Orders Nexstim NBS 6 System

Nexstim
Press release2026-08-21 08:00

Nexstim Receives NBS 6 System Order for a European hospital and existing Nexstim customer

Nexstim
Regulatory press release2026-08-20 12:00

Nexstim Plc: Managers’ Transactions, Weckroth

Nexstim
Press release2026-08-19 08:00

Nexstim Receives NBS 6 Therapy System Order from New US Customer

Nexstim
Nexstim H1'26: Brainlab potential to be weighed later this year
Research2026-08-17 09:09 by
Antti Siltanen

Nexstim H1'26: Brainlab potential to be weighed later this year

Concrete evidence of the Brainlab collaboration's potential will be available during the rest of the year.

Nexstim
Regulatory press release2026-08-14 08:00

NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 – JUNE 30, 2026 (UNAUDITED)

Nexstim
Press release2026-08-11 08:00

Notice of Nexstim Plc’s Half-Year Report H1 2026

Nexstim
Nexstim H1'26 preview: Our expectations for the beginning of the year are moderate
Analyst Comment2026-08-11 08:25 by
Antti Siltanen

Nexstim H1'26 preview: Our expectations for the beginning of the year are moderate

We expect the dip in recurring revenue to have weighed on earnings.

Nexstim
Press release2026-07-31 12:00

Finnish Private Clinic Group Orders Additional Nexstim NBS 6 System

Nexstim
Regulatory press release2026-07-20 12:00

Nexstim Plc: Disclosure of major holdings under Chapter 9, Section 10 of the Finnish Securities Markets Act

Nexstim
Press release2026-07-17 08:00

Delve Psychiatry Upgrades to Nexstim's Latest NBS 6 Platform

Nexstim
Press release2026-07-15 08:00

Nexstim Receives NBS 6 Therapy System Order from a Neurology Clinic in the United States

Nexstim
Nexstim received another order for ten NBS 6 systems
Analyst Comment2026-07-15 08:01 by
Frans-Mikael Rostedt

Nexstim received another order for ten NBS 6 systems

The second order for ten systems within a month indicates the rapid scaling of the distribution partnership.

Nexstim
Press release2026-07-14 08:00

Nexstim Receives a New Order for Ten NBS 6 Systems from Distributor

Nexstim
Press release2026-07-10 08:00

Nexstim Receives Expanded Health Canada Approval for NBS 6 Diagnostics and Pain Applications

Nexstim
Press release2026-07-08 08:00

Nexstim Secures First NBS 6 Sale Following Malaysian Market Authorization

Nexstim